Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06940687 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neurophysiological Benefits of Live Music for Early Alzheimer's Patients and Their Caregivers

StatusActive, Not Recruiting
PhaseNot applicable
Started2025-01-28
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 4, 2026 (before its estimated September 22, 2026 completion). Its status may not reflect the trial's current state.
Trial flagged as At Risk
Primary completion moved at least 6 months later Mar 22, 2026 → Sep 22, 2026
See other at-risk trials from Yale University

Amendment history

2026-09-01
Study Status v2
Trial status changed: Enrolling by Invitation → Active, Not Recruiting
Primary completion pushed: 2026-03-22 → 2026-09-22
Completion pushed: 2026-03-22 → 2026-09-22
2026-02-09
Recruiting→Enrolling by Invitation Study Status, Contacts/Locations v1
Trial statusRecruiting→Enrolling by Invitation
Primary completion date2025-08→2026-03-22
Completion date2025-08→2026-03-22
Study sitesdetails revised at 2 of 2 sites
2025-04-15
Original filing
Yale University
487 trials monitored
See 35 trials at risk
Alzheimer's Disease
1,140 trials monitored
See 62 trials at risk
Dementia
912 trials monitored
See 44 trials at risk
This study aims to investigate the neurophysiological effects of live music on individuals with early Alzheimer's Disease (AD), dementia, and/or mild cognitive impairment (MCI) and their caregivers. Heart rate (HR), heart rate variability (HRV), and brain activity will be measured as participant-caregiver dyads listen to preferred and improvised music performed by professional musicians. Investigators will leverage various measurement techniques including, but not limited to, electroencephalography (EEG), behavioral, surveys, and physiological monitoring to study the impact of live music on anxiety in AD and inter-dyad synchrony.
Trial Details
NCT Number NCT06940687
Lead Sponsor Yale University
Collaborators: Renée Fleming Foundation, Howard University, NeuroArts Blueprint Initiative
Conditions Alzheimer Disease, Dementia, Mild Cognitive Impairment, Peer-bonded Caregiver, Caregiver
Enrollment 60 participants
Start Date 2025-01-28
Primary Completion 2026-09-22 (estimated)
Study Completion 2026-09-22 (estimated)
Updated on ClinicalTrials.gov 2026-09-04